Table 1:
Group | 0–4 yr | 5–9 yr | 10–16 yr | 0–16 yr |
---|---|---|---|---|
Baseline cohort | ||||
♂ | 10 | 11 | 20 | 41 |
♀ | 7 | 7 | 20 | 34 |
Total (No.) | 17 | 18 | 40 | 75 |
Follow-up cohort | ||||
♂ | 17 | 17 | 21 | 55 |
♀ | 8 | 9 | 32 | 49 |
Total (No.) | 25 | 26 | 53 | 104 |
Group | 0–4 yr | 5–9 yr | 10–16 yr | 0–16 yr |
---|---|---|---|---|
Baseline cohort | ||||
♂ | 10 | 11 | 20 | 41 |
♀ | 7 | 7 | 20 | 34 |
Total (No.) | 17 | 18 | 40 | 75 |
Follow-up cohort | ||||
♂ | 17 | 17 | 21 | 55 |
♀ | 8 | 9 | 32 | 49 |
Total (No.) | 25 | 26 | 53 | 104 |